Patent · US Expired

Nanoparticulate topiramate formulations

US7390505B2 · kind B2 · utility

10Cited by
75References
107Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2004
Grant dateJun 24, 2008
Priority date
Expiry dateJun 25, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate compositions comprising topiramate. The topiramate particles of the composition have an effective average particle size of less than about 2 microns.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.